Sittner & Nelson, LLC Organon & Co. Transaction History

Sittner & Nelson, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$17.45 - $21.96 $540 - $680	-31 Reduced 23.85%	99 $2,000
Q1 2024 May 10, 2024	SELL	$13.78 - $18.8 $1,129 - $1,541	-82 Reduced 38.68%	130 $2,000
Q4 2023 Feb 12, 2024	SELL	$10.95 - $17.32 $109 - $173	-10 Reduced 4.5%	212 $3,000
Q3 2023 Nov 13, 2023	SELL	$16.59 - $23.77 $248 - $356	-15 Reduced 6.33%	222 $3,000
Q4 2022 Feb 01, 2023	BUY	$23.31 - $28.61 $1,375 - $1,687	59 Added 33.15%	237 $6,000
Q3 2022 Nov 14, 2022	SELL	$23.4 - $34.25 $280 - $411	-12 Reduced 6.32%	178 $4,000
Q1 2022 May 10, 2022	SELL	$30.45 - $39.36 $4,232 - $5,471	-139 Reduced 42.25%	190 $7,000
Q4 2021 Feb 09, 2022	SELL	$28.67 - $37.13 $1,118 - $1,448	-39 Reduced 10.6%	329 $10,000
Q3 2021 Nov 12, 2021	BUY	$28.63 - $35.64 $10,535 - $13,115	368 New	368 $12,000

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Sittner & Nelson, LLC, based on Form 13F filings with the SEC.

Stay updated on Sittner & Nelson, LLC with notifications on news.